Adipocytokines and the metabolic syndrome among older persons with and without obesity: The InCHIANTI study

Clinical Endocrinology

Volumn 73, Issue 1, 2010, Pages 55-65

  Stenholm, Sari ^a,b   Koster, Annemarie ^c   Alley, Dawn E ^d   Visser, Marjolein ^e   Maggio, Marcello ^f   Harris, Tamara B ^c   Egan, Josephine M ^c   Bandinelli, Stefania ^g   Guralnik, Jack M ^c   Ferrucci, Luigi ^a  

^a HARBOR HOSPITAL   (United States)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF AMSTERDAM   (Netherlands)

^f UNIVERSITY OF PARMA   (Italy)

^g Geriatric Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; LEPTIN; RESISTIN; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; UNCLASSIFIED DRUG; INTERLEUKIN 18; TUMOR NECROSIS FACTOR RECEPTOR 1;

ABDOMINAL OBESITY; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; INSULIN RESISTANCE; ITALY; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN FUNCTION; WAIST CIRCUMFERENCE; BLOOD; COMPLICATION; CROSS-SECTIONAL STUDY; FEMALE; MALE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADIPOKINES; ADIPONECTIN; AGED; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-18; INTERLEUKIN-6; LEPTIN; MALE; METABOLIC SYNDROME X; OBESITY, ABDOMINAL; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RESISTIN;

EID: 77953758101     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2009.03742.x     Document Type: Article

References (50)

1. World Health Organization (2000) Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. WHO Technical Report Series 894
2. Stefan, N., Kantartzis, K., Machann, J. et al. (2008) Identification and characterization of metabolically benign obesity in humans. Archives of Internal Medicine, 168, 1609 1616.
3. Wildman, R.P., Muntner, P., Reynolds, K. et al. (2008) The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Archives of Internal Medicine, 168, 1617 1624.
4. Karelis, A.D., St-Pierre, D.H., Conus, F. et al. (2004) Metabolic and body composition factors in subgroups of obesity: what do we know? Journal of Clinical Endocrinology and Metabolism, 89, 2569 2575.
5. Bastard, J.P., Maachi, M., Lagathu, C. et al. (2006) Recent advances in the relationship between obesity, inflammation, and insulin resistance. European Cytokine Network, 17, 4 12.
6. Tilg, H. Moschen, A.R. (2006) Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology, 6, 772 783.
7. You, T., Nicklas, B.J., Ding, J. et al. (2008) The metabolic syndrome is associated with circulating adipokines in older adults across a wide range of adiposity. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 63, 414 419.
8. Ferrucci, L., Bandinelli, S., Benvenuti, E. et al. (2000) Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. Journal of American Geriatrics Society, 48, 1618 1625.
9. Grundy, S.M., Cleeman, J.I., Daniels, S.R. et al. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735 2752.
10. Matthews, D.R., Hosker, J.P., Rudenski, A.S. et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412 419.
11. Bonora, E., Targher, G., Alberiche, M. et al. (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care, 23, 57 63.
12. Hung, J., McQuillan, B.M., Chapman, C.M. et al. (2005) Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 1268 1273.
13. Hung, J., McQuillan, B.M., Thompson, P.L. et al. (2008) Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. International Journal of Obesity 2005, 32.
14. Rasouli, N. Kern, P.A. (2008) Adipocytokines and the metabolic complications of obesity. Journal of Clinical Endocrinology and Metabolism, 93, S64 S73.
15. Gabay, C., Smith, M.F., Eidlen, D. et al. (1997) Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. Journal of Clinical Investigation, 99, 2930 2940.
16. Dibbs, Z., Thornby, J., White, B.G. et al. (1999) Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials. Journal of the American College of Cardiology, 33, 1935 1942.
17. Pisani, P., Faggiano, F., Krogh, V. et al. (1997) Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. International Journal of Epidemiology, 26 (Suppl. 1 S152 S160.
18. Guralnik, J., Fried, L., Simonsick, E. et al. (1995) The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability. National Institute on Aging, NIH Publication No. 95-4009
19. St-Onge, M.P., Janssen, I. Heymsfield, S.B. (2004) Metabolic syndrome in normal-weight Americans: new definition of the metabolically obese, normal-weight individual. Diabetes Care, 27, 2222 2228.
20. Zamboni, M., Zoico, E., Fantin, F. et al. (2004) Relation between leptin and the metabolic syndrome in elderly women. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 59, 396 400.
21. Maggio, M., Lauretani, F., Ceda, G.P. et al. (2006) Association between hormones and metabolic syndrome in older Italian men. Journal of American Geriatrics Society, 54, 1832 1838.
22. Hivert, M.F., Sullivan, L.M., Fox, C.S. et al. (2008) Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance. Journal of Clinical Endocrinology and Metabolism, 93, 3165 3172.
23. You, T., Ryan, A.S. Nicklas, B.J. (2004) The metabolic syndrome in obese postmenopausal women: relationship to body composition, visceral fat, and inflammation. Journal of Clinical Endocrinology and Metabolism, 89, 5517 5522.
24. Abbatecola, A.M., Ferrucci, L., Grella, R. et al. (2004) Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly. Journal of American Geriatrics Society, 52, 399 404.
25. Grell, M. (1995) Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF. Journal of Inflammation, 47, 8 17.
26. Matsushita, K., Yatsuya, H., Tamakoshi, K. et al. (2006) Comparison of circulating adiponectin and proinflammatory markers regarding their association with metabolic syndrome in Japanese men. Arteriosclerosis, Thrombosis, and Vascular Biology, 26, 871 876.
27. Whitehead, J.P., Richards, A.A., Hickman, I.J. et al. (2006) Adiponectin - a key adipokine in the metabolic syndrome. Diabetes, Obesity and Metabolism, 8, 264 280.
28. Ridker, P.M., Wilson, P.W. Grundy, S.M. (2004) Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation, 109, 2818 2825.
29. Karelis, A.D., Faraj, M., Bastard, J.P. et al. (2005) The metabolically healthy but obese individual presents a favorable inflammation profile. Journal of Clinical Endocrinology and Metabolism, 90, 4145 4150.
30. Kantartzis, K., Rittig, K., Balletshofer, B. et al. (2006) The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity. Clinical Chemistry, 52, 1934 1942.
31. Kantartzis, K., Fritsche, A., Tschritter, O. et al. (2005) The association between plasma adiponectin and insulin sensitivity in humans depends on obesity. Obesity Research, 13, 1683 1691.
32. Qasim, A.N., Metkus, T.S., Tadesse, M. et al. (2009) Resistin gene variation is associated with systemic inflammation but not plasma adipokine levels, metabolic syndrome or coronary atherosclerosis in nondiabetic Caucasians. Clinical Endocrinology, 70, 698 705.
33. Goodpaster, B.H., Krishnaswami, S., Harris, T.B. et al. (2005) Obesity, regional body fat distribution, and the metabolic syndrome in older men and women. Archives of Internal Medicine, 165, 777 783.
34. Stefan, N., Kantartzis, K. Haring, H.U. (2008) Causes and metabolic consequences of fatty liver. Endocrine Reviews, 29, 939 960.
35. Seppälä-Lindroos, A., Vehkavaara, S., Häkkinen, A.M. et al. (2002) Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. Journal of Clinical Endocrinology and Metabolism, 87, 3023 3028.
36. Colbert, L.H., Visser, M., Simonsick, E.M. et al. (2004) Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. Journal of the American Geriatrics Society, 52, 1098 1104.
37. You, T. Nicklas, B.J. (2008) Effects of exercise on adipokines and the metabolic syndrome. Current Diabetes Reports, 8, 7 11.
38. Kondo, T., Kobayashi, I. Murakami, M. (2006) Effect of exercise on circulating adipokine levels in obese young women. Endocrine Journal, 53, 189 195.
39. Ross, R., Janssen, I., Dawson, J. et al. (2004) Exercise-induced reduction in obesity and insulin resistance in women: a randomized controlled trial. Obesity Research, 12, 789 798.
40. Thompson, P.D., Crouse, S.F., Goodpaster, B. et al. (2001) The acute versus the chronic response to exercise. Medicine and Science in Sports and Exercise, 33, S438 S445 discussion S452-S433.
41. Kraus, W.E., Houmard, J.A., Duscha, B.D. et al. (2002) Effects of the amount and intensity of exercise on plasma lipoproteins. New England Journal of Medicine, 347, 1483 1492.
42. Conus, F., Allison, D.B., Rabasa-Lhoret, R. et al. (2004) Metabolic and behavioral characteristics of metabolically obese but normal-weight women. Journal of Clinical Endocrinology and Metabolism, 89, 5013 5020.
43. Blair, S.N., Cheng, Y. Holder, J.S. (2001) Is physical activity or physical fitness more important in defining health benefits? Medicine and Science in Sports and Exercise, 33, S379 S399 discussion S419-S320.
44. St-Pierre, A.C., Cantin, B., Mauriege, P. et al. (2005) Insulin resistance syndrome, body mass index and the risk of ischemic heart disease. Canadian Medical Association Journal, 172, 1301 1305.
45. Stenholm, S., Koster, A., Alley, D. et al. (2009) Joint association of obesity and metabolic syndrome with incident mobility limitation in older men and women - Results from the Health, Aging and Body Composition Study. Journal of Gerontology: Biol Sci Med Sci, doi:.
46. Fontana, L., Eagon, J.C., Trujillo, M.E. et al. (2007) Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes, 56, 1010 1013.
47. Reilly, M.P. Rader, D.J. (2003) The metabolic syndrome: more than the sum of its parts? Circulation, 108, 1546 1551.
48. Wallace, T.M. Matthews, D.R. (2002) The assessment of insulin resistance in man. Diabetic Medicine, 19, 527 534.
49. Kahn, R., Buse, J., Ferrannini, E. et al. (2005) The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care, 28, 2289 2304. (Pubitemid 41242486)
50. Butler, J., Rodondi, N., Zhu, Y. et al. (2006) Metabolic syndrome and the risk of cardiovascular disease in older adults. Journal of the American College of Cardiology, 47, 1595 1602.